Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.
An A1400G mutation of the rrs gene was identified in Mycobacterium tuberculosis (MTB) strain ATCC 35827 and in 13 MTB clinical isolates resistant to amikacin-kanamycin (MICs, >128 microg/ml). High-level cross-resistance may result from such a mutation since MTB has a single copy of the rrs gene. Another mechanism(s) may account for high-level amikacin-kanamycin resistance in two mutants and lower levels of resistance in four clinical isolates, all lacking the A1400G mutation.
Alangaden
G J
GJ
Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. galangaden@oncgate.roc.wayne.edu
Kreiswirth
B N
BN
Aouad
A
A
Khetarpal
M
M
Igno
F R
FR
Moghazeh
S L
SL
Manavathu
E K
EK
Lerner
S A
SA
D000583:Amikacin / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology*; D018432:Drug Resistance, Multiple / Q000235:genetics*; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D005798:Genes, Bacterial / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D007613:Kanamycin Resistance / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics*
D000995:Antitubercular Agents; D007612:Kanamycin; D000583:Amikacin